Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Optimark (Gadoversetamide) in Pediatric Patients

Clinical trial NCT01092754 · COMPLETED

Trial details

NCT number: NCT01092754
Sponsor: Guerbet
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pathological Processes

Start date: 2002-05-01
Primary completion: 2003-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.